Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
382 studies found for:    HIV AND (coinfection OR tuberculosis OR TB OR malaria OR hepatitis OR HCV OR HBV OR HPV OR human papillomavirus OR Kaposi's Sarcoma OR KS OR EBV OR Epstein-Barr) | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
HIV AND (coinfection OR tuberculosis OR TB OR malaria OR hepatitis OR HCV OR HBV OR HPV OR human papillomavirus OR Kaposi's Sarcoma OR KS OR EBV OR Epstein-Barr) | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Rapid Diagnostics for HIV and Hepatitis
Conditions: HIV Infections;   Hepatitis B Infections;   Hepatitis C Infections
Intervention: Device: Multiplo HBc/HIV/HCV and Reveal HBsAg
2 Unknown  Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
Conditions: Latent Tuberculosis Infection;   HIV Infections;   Tuberculosis
Intervention:
3 Not yet recruiting A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results
Condition: Substance-related Disorders
Interventions: Behavioral: On-site bundled rapid HIV/HCV testing;   Behavioral: Standard of care (SOC)
4 Unknown  Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults
Conditions: Influenza;   HIV;   Tuberculosis
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
5 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
6 Recruiting Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB
Conditions: Acquired Immunodeficiency Syndrome;   Tuberculosis
Interventions: Drug: lopinavir with ritonavir in 1:1 ratio;   Drug: Lopinavir/ritonavir 4:1
7 Unknown  Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Conditions: HIV-hepatitis Co-infection;   HIV Infections
Intervention:
8 Recruiting Brief Intervention for Rural Women at High Risk for HIV/HCV
Conditions: Acquired Immune Deficiency Syndrome Virus;   Hepatitis C;   Drug Abuse
Intervention: Other: MI-based HIV Risk Reduction
9 Not yet recruiting HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection
Conditions: Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: E/C/F/TAF;;   Drug: Ledipasvir-Sofosbuvir
10 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
11 Unknown  Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Conditions: HPV;   HIV
Intervention: Biological: Quadrivalent Human Papillomavirus (6, 11, 16 and 18) vaccine (Gardasil ®)
12 Not yet recruiting Integrating HCV and HIV Screening During the Era of HIV Antigen Testing
Conditions: HIV;   Hepatitis C
Interventions: Behavioral: Questionnaire;   Procedure: Rapid finger stick;   Procedure: Venipuncture
13 Recruiting Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .
Conditions: Hepatitis B;   HIV
Intervention: Biological: Recombinant Hepatitis B Virus Vaccine
14 Recruiting Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana
Conditions: Tuberculosis;   HIV
Intervention:
15 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
Intervention:
16 Recruiting A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes
Conditions: MDR-TB;   HIV
Intervention: Other: NCM-Plus
17 Recruiting Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Conditions: Human Immunodeficiency Virus;   HBV;   Fibrosis, Liver;   Cirrhosis, Liver;   Hepatocellular Carcinoma;   Hepatitis Delta Virus;   Alcoholic Hepatitis
Intervention: Drug: Anti-HIV Agents
18 Recruiting Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: EFV 600 mg
19 Recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT);   Drug: Dasabuvir (DSV);   Drug: Ribavirin (RBV)
20 Unknown  Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients
Condition: HIV
Intervention: Biological: Sci-B-Vac

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years